Bartra, C.; Irisarri, A.; Villoslada, A.; Corpas, R.; Aguirre, S.; GarcÃa-Lara, E.; Suñol, C.; Pallà s, M.; Griñán-Ferré, C.; Sanfeliu, C.
Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer′s Disease Neurodegeneration. Int. J. Mol. Sci. 2022, 23, 15151.
https://doi.org/10.3390/ijms232315151
AMA Style
Bartra C, Irisarri A, Villoslada A, Corpas R, Aguirre S, GarcÃa-Lara E, Suñol C, Pallà s M, Griñán-Ferré C, Sanfeliu C.
Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer′s Disease Neurodegeneration. International Journal of Molecular Sciences. 2022; 23(23):15151.
https://doi.org/10.3390/ijms232315151
Chicago/Turabian Style
Bartra, Clara, Alba Irisarri, Ainhoa Villoslada, Rubén Corpas, Samuel Aguirre, Elisa GarcÃa-Lara, Cristina Suñol, Mercè Pallà s, Christian Griñán-Ferré, and Coral Sanfeliu.
2022. "Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer′s Disease Neurodegeneration" International Journal of Molecular Sciences 23, no. 23: 15151.
https://doi.org/10.3390/ijms232315151
APA Style
Bartra, C., Irisarri, A., Villoslada, A., Corpas, R., Aguirre, S., GarcÃa-Lara, E., Suñol, C., Pallà s, M., Griñán-Ferré, C., & Sanfeliu, C.
(2022). Neuroprotective Epigenetic Changes Induced by Maternal Treatment with an Inhibitor of Soluble Epoxide Hydrolase Prevents Early Alzheimer′s Disease Neurodegeneration. International Journal of Molecular Sciences, 23(23), 15151.
https://doi.org/10.3390/ijms232315151
